One hundred and twenty consecutive patients with paroxysmal tachycardia were personally evaluated in a prospective study. Some outstanding clinical features included the association of paroxysmal tachycardia and primary myocardial disease; the lack of palpitations in some patients with paroxysmal tachycardia; the relation of angina pectoris with paroxysmal tachycardia and coronary artery disease; the association of inferior and strictly posterior wall myocardial infarction with paroxysmal tachycardia; the unique presence of urina spastica in I9 2 per cent ofpatients; and the value of 'hunkering down' and sighing respiration in aborting attacks of rapid heart action. In addition, the role of precipitating factors in the onset of tachycardia and the finding that true paroxysmal atrial tachycardia ('PAT') appears to be an infrequent phenomenon when the entire group of paroxysmal arrhythmias is considered, have been presented. The relative ineffectiveness of digitalis, quinidine, and pronestyl has also been evaluated in a selected group of patients with frequent episodes of rapid heart action. 
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Largely descriptive clinical studies have diminished in frequency. This may reflect the many excellent descriptive studies of the past as well as the present-day preoccupation with methodology. In the past 30 years clinical descriptions of the paroxysmal tachycardias have similarly been uncommon (Campbell and Elliott, 1939; Wolff, I942; Armbrust and Levine, I950; Nadas et al., I952; Jones, I954; Lundberg, I963; Mackenzie and Pascual, I964; Haynal and Matsch, i968) , aside from itextbook reviews and occasional reports of unusual forms of treatment and rare electrocardiographic rhythms. Unlike many of these previous reports, the present study was undertaken prospectively. Several distinctive clinical features were found and evaluated which have hitherto received insufficient attention.
the criterion for the clinical diagnosis of paroxysmal tachycardia and was substantiated by electrocardiogram in IOI patients. Careful attention was given to I9 patients in whom a record of the tachycardia could not be obtained, particularly as to historical reliability. Each of these latter patients had repeated episodes of abrupt onset of tachycardia with symptoms of palpitations.
Seventy-five patients were male and 45 female. The patients have been divided into 5 broad groups aetiologically (Table i) : idiopathic, short PR syndromes, primary myocardial disease, rheumatic heart disease, and coronary heart disease. Hyperthyroidism was not a feature in any patient. The age atonset of paroxysmal tachycardia is listed in Table 2 . A preponderance of tachycardia without a known cause reflects the clinically healthy population from which these patients were drawn. The benignity of paroxysmal tachycardia may be deduced from Table 3 wherein it is evident that recurrent rapid heart action may persist for many years.
Of the IS patients with a short PR syndrome, io had the Wolff-Parkinson-White syndrome (I930): one patient had an atrial reciprocating tachycardia, the probable mechanism for tachycardia in most patients with a short PR syndrome (Luria and Hale, 1970) group.bmj.com on October 30, 2017 -Published by http://heart.bmj.com/ Downloaded from ear infection, urinary tract infection with septicaemia, and recurrent prostatitis were present, respectively. Of considerable note was the association of an upper respiratory infection with all 8 episodes of supraventricular tachycardia in a 2-year-old girl whose paroxysmal tachycardia was first noted at the age of 2 months. A 53-year-old man also had 4 episodes of paroxysmal atrial fibrillation associated with upper respiratory infections within 3 years, and a 77-year-old man had 4 episodes of paroxysmal atrial flutter in 6 years, each associated with prostatitis. 6) Gastrointestinal upset was observed in 8 patients before the onset of paroxysmal tachycardia and was chiefly manifested by extreme t bloating or belching, especially after a large meal.
Palpitations Palpitations are the sine qua non of tachycardia. However, their lack of full reliability was manifest in 8 patients with recurrent rapid heart action who had tachy-4 arrhythmic episodes documented fortuitously by electrocardiogram unassociated with an awareness of the tachycardia. In addition, 4 of these patients had never had palpitations: 2 patients complained of chest pain (angina pectoris) during their attacks, one noted marked shortness of breath, and one became very weak. In the majority, the palpitations were readily noted and very bothersome, though patients with frequent attacks often continued in their daily jobs if no other symptoms arose. Moreover, the rapid heart action was often noted by acquaintancescigarettes in a shirt pocket moving in time to the heart beat, or, as noted by the wife of a patient, movement of the bed in time to the rate of the heart. (Ross, Waldhausen, and Braunwald, I960) and resulting vagal stimulation. The above physical methods of vagal stimulation were usually learned from a physician. Of particular note were the experiments of patients on their own. Seven patients found that by leaning over with the head down, especially in a squatting position, but also from a sitting position, the attack of supraventricular tachycardia could be aborted (Fig.  2) . Three of these patients felt that this might be too conspicuous when at work and had individually modified the position so that they appeared to be tying their shoes. It Prophylaxis The difficulties inherent in evaluating the prophylactic treatment of the paroxysmal tachycardias are readily evident when the history of one of the present patients is examined.
A 40-year-old housewife had 3 to 8 hour episodes of supraventricular tachycardia yearly. Following her third episode of rapid heart action, she was placed on maintenance digitalis therapy which was continued for one and a half years without the occurrence of rapid heart action. The drug was then stopped and for the past two years the patient has been asymptomatic.
Was digitalis effective in this patient ? Obviously no reliable judgement can be made, but the vicissitudes of this paroxysmal disease are self evident. Twenty patients in the present series had episodes of rapid heart action of sufficient frequency -usually once per week but at least once monthly -so that the natural variation in the onset of tachycardia could be held to a miimum (Table 5) . None had ventricular tachycardia or rheumatic heart disease; one had pre-excitation; and 2 had evidence of inferior and strictly posterior wall myocardial infarction. An intricate relation between coronary artery disease and recurrent episodes of paroxysmal tachycardia existed in patients with angina pectoris and myocardial infarction. Since a pronounced tachycardia may conspicuously increase oxygen consumption of the heart, periods of rapid heart action may have represented a natural form of an exercise tolerance test, especially when symptoms typical of angina pectoris were produced in the present patients. Though Wolff (I945) has emphasized that an absence of angina pectoris in paroxysmal tachycardia does not preclude coronary artery disease, patients in the present study without a high probability of coronary artery disease did not develop angina pectoris at heart rates similar to those with pain. The role of myocardial infarction appeared aetiologic. The high incidence of inferior and also strictly posterior wall myocardial infarction may indicate significant disease of the nutrient vessels of the sinus node and its connecting conduction system, i.e. the right coronary artery.
Another relation was found between primary myocardial disease and paroxysmal tachycardia. The customary clinical presentation of patients with primary myocardial disease is either one of congestive heart failure, cardiac restriction, or left ventricular outflow tract obstruction (Goodwin et al., I96I) . The present findings suggest that a fourth chief presenting manifestation is recurrent paroxysmal tachycardia.
Urina spastica is a feature of paroxysmal tachycardia which has gained considerable attention as a result of the writings of Wood (I963). The water diuresis has been attributed to a mechanism involving left atrial distension and subsequent reflex antidiuretic hormone inhibition (Wood, I963; Luria, Adelson, and Lochaya, I966a) . Cardiac output is not raised during the polyuria but creatinine clearance, total solute excretion, and free water clearance are increased (Luria et al., I966a) . The cause of the large solute diuresis is unclear but a selective increase in renal blood flow has been postulated. Previous surveys have also indicated that urina spastica is not found in patients with valvular heart disease. If these latter patients are excluded, approximately one-half of patients with paroxysmal tachycardia are reported to have an associated polyuria (Wood, I963; Luria et al., I966a) . The lower incidence in the present study may reflect the effect of a prospective study. 
